JP2023518430A5 - - Google Patents
Info
- Publication number
- JP2023518430A5 JP2023518430A5 JP2022556099A JP2022556099A JP2023518430A5 JP 2023518430 A5 JP2023518430 A5 JP 2023518430A5 JP 2022556099 A JP2022556099 A JP 2022556099A JP 2022556099 A JP2022556099 A JP 2022556099A JP 2023518430 A5 JP2023518430 A5 JP 2023518430A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- pharmaceutical composition
- therapeutically effective
- effective dose
- approximately
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062991996P | 2020-03-19 | 2020-03-19 | |
| US62/991,996 | 2020-03-19 | ||
| PCT/CA2021/050350 WO2021184115A1 (en) | 2020-03-19 | 2021-03-16 | Use of bucillamine in the treatment of infectious diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023518430A JP2023518430A (ja) | 2023-05-01 |
| JP2023518430A5 true JP2023518430A5 (https=) | 2024-02-02 |
Family
ID=77767915
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022556099A Pending JP2023518430A (ja) | 2020-03-19 | 2021-03-16 | 感染症の治療におけるブシラミンの使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20230172884A1 (https=) |
| EP (1) | EP4121035A4 (https=) |
| JP (1) | JP2023518430A (https=) |
| KR (1) | KR20230015320A (https=) |
| WO (1) | WO2021184115A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3183146A1 (en) * | 2020-05-13 | 2021-11-18 | The Regents Of The University Of California | Thiol-containing compounds for use in treating coronavirus |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6025393A (en) * | 1995-09-25 | 2000-02-15 | Santen Pharmaceutical Co., Ltd. | Method for treatment of inflammatory intestinal diseases |
| WO2010014953A1 (en) * | 2008-08-01 | 2010-02-04 | The Regents Of The University Of Colorado, A Body Corporate | Prolonged administration of a dithiol anti-oxidant protects against ventricular remodeling |
| WO2011094598A2 (en) * | 2010-01-28 | 2011-08-04 | The Johns Hopkins University | Compositions and methods for reversing corticosteroid resistance or treating respiratory infections |
| US20110218241A1 (en) * | 2010-03-06 | 2011-09-08 | Cacao Bio-Technologies, Llc | Antiviral epicatechins, epicatechin oligomers, or thiolated epicatechins from theobroma cacao for treatment of genital warts |
| GB201012889D0 (en) * | 2010-08-02 | 2010-09-15 | Univ Leuven Kath | Antiviral activity of novel bicyclic heterocycles |
| US9238018B2 (en) * | 2012-11-20 | 2016-01-19 | Revive Therapeutics Inc. | Use of bucillamine in the treatment of gout |
| CA3017797A1 (en) * | 2016-03-17 | 2017-09-21 | Thiogenesis Therapeutics, Inc. | Compositions for controlled release of cysteamine and systemic treatment of cysteamine sensitive disorders |
-
2021
- 2021-03-16 KR KR1020227036230A patent/KR20230015320A/ko not_active Withdrawn
- 2021-03-16 EP EP21772039.0A patent/EP4121035A4/en not_active Withdrawn
- 2021-03-16 JP JP2022556099A patent/JP2023518430A/ja active Pending
- 2021-03-16 US US17/912,597 patent/US20230172884A1/en active Pending
- 2021-03-16 WO PCT/CA2021/050350 patent/WO2021184115A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023503309A5 (https=) | ||
| JP2022058688A5 (https=) | ||
| JP2023503303A5 (https=) | ||
| JP2021066744A5 (ja) | ブプロピオンおよびデキストロメトルファンを含む組成物 | |
| JP2023503068A5 (https=) | ||
| JP2023503071A5 (https=) | ||
| HRP20220902T3 (hr) | Pripravci i njihova upotreba u liječenju multiple skleroze | |
| JP2024540183A5 (https=) | ||
| ATE350040T1 (de) | Stabilisierte pharmazeutische zusammensetzung enthaltend einen nichtsteroiden entzündungshemmenden wirkstoff und prostaglandin | |
| JP2018507914A5 (https=) | ||
| JP2014515373A5 (https=) | ||
| JP2005516904A5 (https=) | ||
| MX2020012377A (es) | Uso de tabletas de desintegracion orales de riluzol para el tratamiento de enfermedades. | |
| JP2018531273A5 (https=) | ||
| EA202190544A1 (ru) | Применение распадающихся в полости рта таблеток рилузола для лечения заболеваний | |
| WO2017182873A3 (en) | Peptide-oligourea foldamer compounds and methods of their use | |
| RU2008134143A (ru) | Фармацевтическая композиция цитиколина, холина альфосцерата и l-карнитина (или ацетил-l-карнитина) для лечения и профилактики заболеваний центральной нервной системы и способ лечения | |
| JP2023518430A5 (https=) | ||
| CN101654393A (zh) | 作为肝脏保护剂的化合物和组合物 | |
| JP2019507786A5 (https=) | ||
| JP2024528731A5 (https=) | ||
| JP2022517902A5 (https=) | ||
| JP2021512086A5 (https=) | ||
| RU2013105513A (ru) | Производные 1-аминоалкилциклогексана для лечения воспалительных заболеваний кожи | |
| JP2008533079A5 (https=) |